Predicting 30-Day Mortality Using ST-Segment Elevation Resolution in ST-Elevation Myocardial Infarction Patients

Shankar Chandra Mandal1, Bhushan Shah2, Lokendra Rekwal2

  • 1Department of Cardiology, Institute of Post Graduate Medical Education and Research, Kolkata, IND.

Cureus
|June 8, 2023
PubMed

Insights

ST-segment elevation (STE) resolution after primary percutaneous coronary intervention (pPCI) for ST-elevation myocardial infarction (STEMI) predicts 30-day mortality in Indian patients. Persistent STE indicates higher mortality risk, guiding further interventions.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Clinical Outcomes

Background:

  • Limited data exists on ST-segment elevation (STE) resolution and 30-day mortality in non-Indian populations post-primary percutaneous coronary intervention (pPCI).
  • This study focuses on evaluating the prognostic value of STE resolution in Indian patients with ST-elevation myocardial infarction (STEMI) undergoing pPCI.

Purpose of the Study:

  • To assess the predictive capability of STE resolution for 30-day mortality in Indian STEMI patients treated with pPCI.
  • To investigate the correlation between the extent of STE resolution and major adverse cardiovascular events (MACE) at 30 days.

Main Methods:

  • A prospective, single-center, observational study involving 56 Indian patients with STEMI undergoing pPCI.
  • Patients were categorized by STE resolution: complete (≥70%), partial (30-70%), and none (<30%).
  • Primary endpoint included all-cause death, reinfarction, stroke, and target vessel revascularization within 30 days.

Main Results:

  • Mortality rates were 2.1% for partial and 33.3% for no STE resolution; no deaths occurred with complete resolution.
  • Significant differences in 30-day survival were observed across the three STE resolution groups (P<0.01).
  • STE resolution independently predicted 30-day mortality, even in patients with post-PCI TIMI 3 flow.

Conclusions:

  • Persistent STE after pPCI is a reliable predictor of 30-day mortality in Indian STEMI patients.
  • The degree of STE resolution serves as a cost-effective tool for early mortality risk stratification.
  • Patients with persistent STE require focused interventions due to their elevated 30-day mortality risk.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
33
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
11
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
13
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
22